CDIO · Cardio Diagnostics Holdings, Inc.
$1.56
-0.06 (-3.70%)
At close · Jul 28
Market Cap
$4.79M
Shares
2.96M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$1.62
Open$1.54
Day$1.45–1.71
52W$0.97–7.91
Avg vol 30d35K
Short int5K · 0.2% float · 1.0d
Short vol23%
DataJan 2022–Jul 2026
Filing10-Q · May 15
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 15, 2026
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Strong Sell
Momentum
Weak
Sentiment
Neutral
Fundamentals
Weak
Quant / Vol
Very High
Market backdrop
VIX 18.7 · elevated
Equity put/call 0.66
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−38%
below
Price vs 50-day avg
−13%
below
RSI (14)
35
neutral
MACD trend
Negative
52-week position
9%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−20%
trailing
6-month return
+7%
trailing
YTD return
−40%
this year
Relative strength
0%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $2 › 200d $3 — 200d above 50d
Institutional flow
Flat
1 of 16 funds reported for Jun 30 · net 0 sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.15% of float · ▼ -77.5% MoM · 1.0 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Steady
16 holders — mid 1-yr range
Squeeze score
24
low risk · 0–100
Fundamentals
Revenue growth
−58%
Y/Y
EPS growth
+60%
Y/Y
Free cash flow
$-5.9M
Balance sheet
$0
net cash
Quant / Vol
risk profile
Volatility
148%
annualized · 1-yr
Max drawdown
−79%
past year
ATR
9.6%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Strong Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−38%
Bearish
Price vs 50-day avg
−13%
Bearish
RSI (14)
35
Neutral
MACD trend
Negative
Bearish
52-week position
9%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 1 of 6
Trend (MA cross)
No cross
50d $2 › 200d $3 — 200d above 50d
Institutional flow
Flat
1 of 16 funds reported for Jun 30 · net 0 sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.15% of float · ▼ -77.5% MoM · 1.0 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Steady
16 holders — mid 1-yr range
Price context
position in its 52-week range
52-wk low $1
Now $2 · 9%
52-wk high $8
vs 200-day avg -38%
vs 50-day avg -13%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CDIO
this stock
Cardio Diagnostics Holdings, Inc.
|
$4.79M | -40.2% | -57.5% | — | 0.2% |
|
ONC
BeOne Medicines Ltd.
|
$471.01B | +7.3% | +22179.2% | 958.5 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$121.57B | +5.7% | +46.2% | 28.4 | 2.0% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$69.95B | -13.5% | +20.8% | 16.3 | 3.3% |
|
ARGX
Argenx SE
|
$55.61B | +5.7% | — | — | 2.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CDIO | -5.8% | -19.8% | +7.3% | -26.0% | -40.2% |
| SPY | -0.6% | +0.7% | +6.8% | -1.0% | +8.4% |
| vs SPY | -5.2% | -20.5% | +0.5% | -25.0% | -48.6% |